Corneal epithelial cell bandage to treat persistent epithelial defect
Corneal epithelial cell bandage to treat persistent epithelial defect
批准号:
MR/Y019385/1
负责人:
Hannah Levis
金额:
$225.79万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Corneal would healing is essential to maintain the integrity of the cornea. In a healthy eye, after an insult to the ocular surface, the epithelial defect is repaired by a complex re-epithelialisation process. Healing may be delayed or halted in compromised conditions leaving the underlying stroma vulnerable to further trauma, infiltrates, infection, scarring and perforation. A persistent epithelial defect is defined as a defect that is not resolved after 2 weeks of standard treatment. There are risk factors that confound corneal epithelial wound healing including diabetic keratopathy, limbal stem cell deficiency, dry eye disease, neurotrophic keratopathy and herpetic infection to name a few. The current treatments for persistent epithelial defect can include lubricating eye drops, punctal occlusion to provide a more lubricious environment, bandage contact lenses, serum, tarsorrhaphy or amniotic membrane transplant. Standard treatments tend to be ineffective, prolonging patient discomfort and diminished visual acuity. Due to the complex nature of the disease, patients must be examined multiple times a week, with some patients requiring up to 90 visits a year. The economic impact of this on health systems is substantial. We are developing an alternative treatment that involves transfer of corneal epithelial cells to the ocular surface directly via a soft contact lens. Our 'cell bandage' will enable rapid healing of the wound by the transplanted cells with the additional benefit provided by the contact lens element of the therapy of the protection from shearing forces that occur when blinking. We have proof of principle that the cell bandage functions to heal wounds in vitro but we need to test its effectiveness in a model using human eyes in the lab and its safety in a whole animal model. If the cell bandage provides favourable results we will continue to develop the product working with cell therapy manufacturers to determine a production method suitable for use in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bio-synthetic corneal endothelial grafts for transplantation
-
批准号:MR/W01470X/1
-
项目类别:Research Grant
-
资助金额:$144.07万
-
财政年份:2022
-
负责人:Hannah Levis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TRIM25-PHGDH信号轴调控脓毒症肺上皮细胞铁死亡的机制研究
-
批准号:82372151
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:童尧
-
依托单位:
基于压力敏感肾单位微流控芯片的肾上皮细胞CAT1-mTOR通路在梗阻性肾损伤中的作用机制研究
-
批准号:82370678
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:林厚维
-
依托单位:
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
-
批准号:82371691
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张健
-
依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
KLF2蛋白通过反馈抑制TGF-β信号减弱肝癌细胞EMT和运动能力的分子机理
-
批准号:32060162
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:涂硕
-
依托单位:
Ufmylation修饰在肿瘤细胞上皮间质转化中的作用和机制研究
-
批准号:31900520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:梁千
-
依托单位:
E3泛素连接酶RNF8在肺癌转移中的作用及机制研究
-
批准号:31900537
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:匡静宇
-
依托单位:
上皮钠离子通道(ENaC)在血管内皮的功能和作用
-
批准号:81170236
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:顾雨春
-
依托单位: